Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas
M Fillpits , RW Suchomel , G Dekan , W Stiglbauer
British Journal of Cancer 75 ( 2) 208 -212
31
1997
CDK10 Is Not a Target for Aberrant DNA Methylation in Breast Cancer
Gerwin Heller , Barbara Ziegler , Anita Brandstetter , Sabine Novak
Anticancer Research 29 ( 10) 3939 -3944
12
2009
MRP and MDR1 gene expression in primary breast carcinomas.
Martin Filipits , Ralf W Suchomel , Gerhard Dekan , Karin Haider
Clinical Cancer Research 2 ( 7) 1231 -1237
83
1996
Very early detection of small clones harbouring EGFR mutations in NSCLC by 2nd generation sequencing
Claudia Vollbrecht , Fabian Mairinger , Slave Trajanoski , Iris Halbwedl
European Respiratory Journal 38 1956
2011
Cetuximab in non-small-cell lung cancer.
Robert Pirker , Martin Filipits ,
Translational lung cancer research 1 ( 1) 54 -60
17
2012
Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas.
Martin Filipits , Ulrich Jaeger , Ingrid Simonitsch , Claudia Chizzali-Bonfadin
Clinical Cancer Research 6 ( 9) 3417 -3423
25
2000
Expression of the Lung Resistance Protein Predicts Poor Outcome in Patients with Multiple Myeloma
Martin Filipits , Johannes Drach , Gudrun Pohl , Judith Schuster
Clinical Cancer Research 5 ( 9) 2426 -2430
42
1999
Low protein expression of MET in ER-positive and HER2-positive breast cancer.
Flora Zagouri , Anita Brandstetter , Dimitrios Moussiolis , Dimosthenis Chrysikos
Anticancer Research 34 ( 3) 1227 -1231
6
2014
Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myeloma.
Martin Filipits , Gudrun Pohl , Thomas Stranzl , Hannes Kaufmann
Clinical Cancer Research 9 ( 2) 820 -826
30
2003
Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma.
Martin Filipits , Ulrich Jaeger , Gudrun Pohl , Thomas Stranzl
Clinical Cancer Research 8 ( 3) 729 -733
73
2002
E-Cadherin and β-Catenin Expression in Normal, Inflamed and Cancerous Gallbladder Tissue
Harald Puhalla , Beate Herberger , Afschin Soleiman , Martin Filipits
Anticancer Research 25 4249 -4254
12
2005
O3. Registry study in NSCLC patients with EGFR, ALK, or ROS1 mutations
Martin Filipits
Translational lung cancer research 3 ( 5)
2
2014
Alectinib in RET-rearranged non-small cell lung cancer-Another progress in precision medicine?
Robert Pirker , Martin Filipits ,
Translational lung cancer research 4 ( 6) 797 -800
8
2015
Expression of the lung resistance protein in primary colorectal carcinomas.
Gudrun Pohl , Ralf W Suchomel , Thomas Stranzl , Dieter Depisch
Anticancer Research 21 201 -204
5
2001
Low p27Kip1 expression is an independent prognostic factor in gallbladder carcinoma.
Martin Filipits , Harald Puhalla , Friedrich Wrba ,
Anticancer Research 23 675 -679
25
2003
Osimertinib in advanced EGFR T790M-positive non-small-cell lung cancer: the clinical impact of AURA3
Robert Pirker , Anna Buder , Martin Filipits ,
Translational cancer research 6 ( 2)
1
2017
Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients.
Klaus Hackner , Anna Buder , Maximilian J Hochmair , Matthaeus Strieder
Clinical Medicine Insights: Oncology 15 1179554921993072 -1179554921993072
2021
Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34.
Rupert Bartsch , Christian F Singer , Georg Pfeiler , Michael Hubalek
British Journal of Cancer 124 ( 11) 1795 -1802
2021
Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study
Luka Brcic , Thomas Klikovits , Zsolt Megyesfalvi , Berta Mosleh
Translational lung cancer research 10 ( 4) 1594 -1607
2021
Somatic Copy-Number Alterations in Plasma Circulating Tumor DNA from Advanced EGFR-Mutated Lung Adenocarcinoma Patients.
Anna Buder , Ellen Heitzer , Julie Waldispühl-Geigl , Sabrina Weber
Biomolecules 11 ( 5) 618
2021